Azcárate, Isabel G. Bautista, José M. Díez, Amalia Marín García, Patricia Puyet, Antonio
Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin. [artículo] - British journal of pharmacology, 2013 - 169(3):645-58.
Formato Vancouver:
Azcárate IG, Marín-García P, Camacho N, Pérez-Benavente S, Puyet A, Diez A et al. Insights into the preclinical treatment of
blood-stage malaria by the antibiotic borrelidin. Br J Pharmacol. 2013 Jun;169(3):645-58.
PMID: 23488671
Contiene 69 referencias
BACKGROUND AND PURPOSE: Blood-stage Plasmodium parasites cause morbidity and mortality from malaria. Parasite resistance to drugs makes development of new chemotherapies an urgency. Aminoacyl-tRNA synthetases have been validated as antimalarial drug targets. We explored long-term effects of borrelidin and mupirocin in lethal P. yoelii murine malaria.
Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin. [artículo] - British journal of pharmacology, 2013 - 169(3):645-58.
Formato Vancouver:
Azcárate IG, Marín-García P, Camacho N, Pérez-Benavente S, Puyet A, Diez A et al. Insights into the preclinical treatment of
blood-stage malaria by the antibiotic borrelidin. Br J Pharmacol. 2013 Jun;169(3):645-58.
PMID: 23488671
Contiene 69 referencias
BACKGROUND AND PURPOSE: Blood-stage Plasmodium parasites cause morbidity and mortality from malaria. Parasite resistance to drugs makes development of new chemotherapies an urgency. Aminoacyl-tRNA synthetases have been validated as antimalarial drug targets. We explored long-term effects of borrelidin and mupirocin in lethal P. yoelii murine malaria.
